跳至主要内容
临床试验/ACTRN12619000995178
ACTRN12619000995178招募中3 期

Surfactant administration by either supraglottic airway device (SAD) or direct laryngoscopy in late preterm and term newborns on nasal continuous positive airway pressure (nCPAP): A randomised, multi-centre, non-inferiority trial

Women's and Children's Hospital0 个研究点目标入组 148 人开始时间: 2019年7月12日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 24 Hours(—)
性别
All

入选标准

  • Infants are eligible for inclusion in the study if:
  • They are born at >33 weeks GA by best obstetric estimate and have a birth weight of >1500g; and
  • They are <24 hours old at the time of randomisation; and
  • They require nasal continuous positive airway pressure (nCPAP) after admission for moderate-to-severe respiratory distress, hypoxia or hypercapnia where the treating clinician has determined surfactant therapy is indicated and it is felt unlikely ongoing mechanical ventilation is required.

排除标准

  • Infants are excluded from the trial if:
  • They have a known major congenital abnormality that may impact on the infants’ condition (including complex congenital cardiac disease, upper airway obstruction or complex airway abnormality, gastro-intestinal malformation; and
  • They have previously been intubated (including intubation for suctioning below the cords in the delivery suite), or immediately need intubation, as a determined by the attending clinician.

研究者

发起方
Women's and Children's Hospital

相似试验

已完成
不适用
surfactant administration via laryngeal mask airway versus endotracheal tube in severe neonatal respiratory distress syndromeRespiratory distress syndrome of newborn.Hyaline membrane disease
IRCT201602019568N14Tehran University of Medical Sciences60
招募中
不适用
A study to see a more appropriate strategy to provide surfactant for lung maturation in premature neonates
CTRI/2018/07/015121All India Instiute of Medical Sciences AIIMS New Delhi
招募中
不适用
Early intratracheal treatment with surfactant plus steroids (SurPluS) in low birth-weight premature infants following preterm premature rupture of the membranes-clincal course and outcomeP23.9P25.1P26.8P28.5P27.1P52.0P52.1P52.2P52.4P36.9P39.9P77P78.0P91.1H35.1Intracerebral (nontraumatic) haemorrhage of fetus and newbornBacterial sepsis of newborn, unspecifiedInfection specific to the perinatal period, unspecifiedCongenital pneumonia, unspecifiedPneumothorax originating in the perinatal periodOther pulmonary haemorrhages originating in the perinatal periodRespiratory failure of newbornBronchopulmonary dysplasia originating in the perinatal periodIntraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newbornIntraventricular (nontraumatic) haemorrhage, grade 2, of fetus and newbornIntraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newbornNecrotizing enterocolitis of fetus and newbornPerinatal intestinal perforationAcquired periventricular cysts of newbornRetinopathy of prematurity
DRKS00021504niversität zu Lübeck186
尚未招募
4 期
Comparison of surfactant delivery methods - Endotracheal tube vs Laryngeal mask airway
CTRI/2023/07/054608Srikanth kandi
已完成
不适用
Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope - the VISUAL MethodRespiratory Distress Syndrome, Newborn
NCT04406142Carmel Medical Center23